BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
-6.2%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$20.6B
AUM Growth
+$20.6B
Cap. Flow
+$41.1M
Cap. Flow %
0.2%
Top 10 Hldgs %
83.49%
Holding
127
New
5
Increased
17
Reduced
8
Closed
5
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TNGX icon
76
Tango Therapeutics
TNGX
$745M
$8.21M 0.04%
750,000
FGEN icon
77
FibroGen
FGEN
$48.4M
$8.18M 0.04%
+23,206
New +$8.18M
EWTX icon
78
Edgewise Therapeutics
EWTX
$1.54B
$7.64M 0.04%
500,000
CBAY
79
DELISTED
Cymabay Therapeutics
CBAY
$7.34M 0.04%
2,170,464
MGNX icon
80
MacroGenics
MGNX
$121M
$7.1M 0.03%
442,579
ITOS
81
DELISTED
iTeos Therapeutics
ITOS
$7M 0.03%
150,346
NVAX icon
82
Novavax
NVAX
$1.2B
$6.89M 0.03%
48,168
-60,588
-56% -$8.67M
ALLK
83
DELISTED
Allakos
ALLK
$6.88M 0.03%
703,050
TCRX icon
84
TScan Therapeutics
TCRX
$106M
$6.41M 0.03%
1,425,000
RETA
85
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$5.91M 0.03%
223,976
RVMD icon
86
Revolution Medicines
RVMD
$7.43B
$5.59M 0.03%
222,222
HRMY icon
87
Harmony Biosciences
HRMY
$2.16B
$5.27M 0.03%
123,600
NGM
88
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$5.17M 0.03%
291,801
ALEC icon
89
Alector
ALEC
$282M
$4.94M 0.02%
239,228
ATYR
90
aTyr Pharma
ATYR
$560M
$4.67M 0.02%
625,000
KURA icon
91
Kura Oncology
KURA
$732M
$4.26M 0.02%
304,158
DNLI icon
92
Denali Therapeutics
DNLI
$2.24B
$3.96M 0.02%
88,738
BMEA icon
93
Biomea Fusion
BMEA
$114M
$3.91M 0.02%
524,617
TCRR
94
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$3.51M 0.02%
753,064
+576,603
+327% +$2.69M
GTH
95
DELISTED
Genetron Holdings Limited ADS
GTH
$2.78M 0.01%
151,769
CABA icon
96
Cabaletta Bio
CABA
$144M
$2.51M 0.01%
662,063
AKRO icon
97
Akero Therapeutics
AKRO
$3.65B
$2.5M 0.01%
118,378
VINC
98
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$2.46M 0.01%
12,069
ALBO
99
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$2.43M 0.01%
104,521
-307,945
-75% -$7.17M
SNDX icon
100
Syndax Pharmaceuticals
SNDX
$1.39B
$2.42M 0.01%
110,729